HeartBeam, Inc. (NASDAQ:BEATW – Get Free Report) was the recipient of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 1,400 shares, a ...

Several companies will head to the FDA seeking approval of new Duchenne muscular dystrophy treatments next year but the death of a patient taking Sarepta’s Elevidys raises important safety questions.

1 AKH Linz, Department of Internal Medicine I - Cardiology, Krankenhausstrasse, Austria 2 Department of Cardiology, Medical University of Vienna ... and many other pathophysiological processes of the ...

An estimated 55 million people are believed to be living with dementia, according to health officials. Vascular diseases ...

Cardio-focused company Kardigan is sewing a new digital data platform into its R&D patchwork through the acquisition of heart ...

The FDA-approved imaging agent for detecting coronary artery disease gained Medicare and Medicaid coverage starting April 1.

HUMAN Diagnostics has successfully relaunched its urinalysis portfolio, introducing cutting-edge solutions that enhance ...